Send Inquiry

Request To Call Back

AHABIR ABIRATERONE TABLETS

Get a Price/Quote

MOQ : 100 Bottles

AHABIR ABIRATERONE TABLETS Specification

Salt Composition
Abiraterone Acetate

Origin
India

Indication
Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Dosage Form
Tablet

Feature
Other

Ingredients
Other

Application
Other

Physical Color/Texture
Off-white to light yellow, film-coated tablet

Fermentation Smell
Normal Smell

Storage Instructions
Cool & Dry Place

Shelf Life
24 months

Market Form
Finished Product

Brand Name
AHABIR

Strength
250 mg

Prescription/Non-Prescription
Prescription

Approval
Regulated by Indian FDA guidelines

Packaging Size
120 Tablets per bottle

Route of Administration
Oral

AHABIR ABIRATERONE TABLETS Trade Information

Minimum Order Quantity
100 Bottles

Supply Ability
5000 Bottles Per Month

Delivery Time
7 Days

Packaging Details
PACK OF 120 TABLETS

Main Domestic Market
All India

About AHABIR ABIRATERONE TABLETS

BDescription:-

Brand Name : Ahabir

Content : Abiraterone Acetate Tablets

Strength : Abiraterone IP 250mg

Packing : 120 Tablets

Type : Tablets

Uses : Cancer.

Manufactured by: Hetero Healthcare........................

Advanced Cancer Care Solution

AHABIR Abiraterone Tablets offer a regulated treatment approach for metastatic castration-resistant prostate cancer. Developed according to Indian FDA standards, these tablets present a reliable option for healthcare providers managing advanced cancers. The high-quality formulation ensures therapeutic consistency and patient safety.

Quality Manufacturing & Safety Assurance

Every bottle of AHABIR tablets is produced in India, adhering closely to pharmaceutical industry benchmarks. The finished product is accompanied by clear labeling, safety instructions, and is distributed by trained professionals. Regulatory approval enhances patient confidence in the medicines origin and compliance.

Ease of Administration and Storage

Designed for convenient oral intake, AHABIR tablets are straightforward to use at home or in clinical settings. The shelf life of 24 months, coupled with simple storage requirements, makes it practical for both patients and healthcare providers to integrate into regular treatment plans.

FAQs of AHABIR ABIRATERONE TABLETS:

Q: How should AHABIR Abiraterone Tablets be administered?

A: AHABIR tablets are intended for oral use and must be taken exactly as prescribed by your healthcare provider. They are typically swallowed whole, not to be split or chewed, to ensure accurate dosing and maximum efficacy.

Q: What is the main indication for using AHABIR Abiraterone Tablets?

A: AHABIR Abiraterone Tablets are indicated for the treatment of metastatic castration-resistant prostate cancer (mCRPC), offering targeted therapy for patients whose cancer has advanced despite hormone therapy.

Q: When should AHABIR Abiraterone Tablets be taken during treatment?

A: Your doctor will determine the most suitable dosing schedule for you. Generally, Abiraterone is taken once daily, and your dosage timing is crucial for maintaining stable blood levels and therapeutic effect.

Q: Where is AHABIR Abiraterone Tablets manufactured and distributed?

A: AHABIR tablets are manufactured in India under Indian FDA guidelines. They are distributed via authorized exporters, suppliers, traders, and wholesalers throughout India.

Q: What process ensures the quality and approval of AHABIR Abiraterone Tablets?

A: The production and approval of AHABIR tablets follow strict regulatory protocols set by the Indian FDA, ensuring every batch meets established safety and efficacy standards before being released to the market.

Q: What are the proper storage instructions for AHABIR Abiraterone Tablets?

A: AHABIR tablets should be stored in a cool and dry place, away from direct sunlight and moisture. This helps maintain the quality and effectiveness of the medication throughout its 24-month shelf life.

Q: What benefits does AHABIR Abiraterone provide to patients with mCRPC?

A: Patients using AHABIR Abiraterone Tablets may experience a delay in cancer progression and an improvement in overall survival, as the medication suppresses androgen production, a key driver of prostate cancer growth.

Tell us about your requirement